Hydromer, Inc. has announced a new commercial partnership with Avem Market Solutions that significantly strengthens the company's reach and technical support capabilities for medical device developers throughout Europe and the United Kingdom. This collaboration creates a more accessible path for European device manufacturers who require advanced surface solutions by leveraging Avem's expertise in connecting Medtech OEMs and CDMOs with specialized suppliers. The partnership addresses increasing pressure on European and UK medtech companies to innovate quickly while meeting strict regulatory expectations.
By combining Hydromer's deep scientific expertise with Avem's regional commercial insight, the collaboration aims to make advanced coating solutions easier to access, understand, and implement. As Hydromer's strategic representative in the region, Avem will provide direct access to hydrophilic, lubricious, antimicrobial, and thrombo-resistant coating platforms along with custom formulation and R&D support for early development. Device manufacturers will benefit from earlier visibility into validated coating options, hands-on support for feasibility studies and scale-up, and a reliable resource for navigating technical and operational challenges.
The partnership also provides a direct channel to explore coating technologies proven in global markets, helping developers reduce time to market, enhance device performance, and streamline the transition from prototype to full-scale manufacturing. Hydromer's coatings have been integrated into devices used in interventional, surgical, and diagnostic procedures worldwide for decades. The company's extensive experience in specialty medical coatings and surface technologies, combined with Avem's vast network and on-the-ground presence in European markets, creates a unified approach to supporting medtech innovation.
This strategic alliance is designed to eliminate barriers and empower innovators at every stage of product development, from initial concept through commercialization. The collaboration represents a significant step in making advanced medical coating technologies more accessible to European manufacturers facing complex regulatory landscapes and competitive market pressures. By providing localized commercial guidance from a team immersed in the EU and UK medtech ecosystems, the partnership aims to support the growing demand for sophisticated surface modification solutions that can improve device performance and patient outcomes. Additional information about the partnership can be found at https://www.newmediawire.com.
